Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SC-YN Consultants
- Ownership
- Private
- Development stage
- Other
01
Overview
SC-YN Consultants appears to be a private consulting company rather than a biotechnology, pharmaceutical, or healthcare operating company. Publicly accessible evidence located for this entity is limited and primarily comes from a January 11, 2021 securities disclosure by American Aires Inc., which identified SC-YN Consultants Inc. as a consultant controlled by Yan Namer. No credible evidence was found of a drug pipeline, therapeutic programs, platform technology, or life sciences R&D activities. Based on the available information, the entity is best characterized as a small private consulting business with insufficient public disclosure to support a biotech-style company profile.
- Industry
- Consulting
02
Partnerships
American Aires
Beyond the preview
Go deeper on SC-YN Consultants.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SC-YN Consultants.